Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway.
| Author | |
|---|---|
| Year of Publication | :
2018
|
| Journal | :
Investigational new drugs
|
| Date Published | :
2018
|
| ISSN Number | :
0167-6997
|
| DOI | :
10.1007/s10637-017-0558-5
|
| Short Title | :
Invest New Drugs
|
| Download citation |